SCHEMBL1207431

SCHEMBL1207431

CNC(=O)OCC1CCc2c(sc(NC(=O)C=Cc3cccs3)c2C#N)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.54
NOD1 Q9Y239 3/20 0.53
TNF P01375 2/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
ALDH1A1 P00352 7/20 0.49
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
ALOX15 P16050 1/20 0.45
MAPK1 P28482 1/20 0.45
POLB P06746 6/20 0.45
MAPT P10636 6/20 0.43
RECQL P46063 1/20 0.43
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
NR0B1 P51843 1/20 0.43
TGFBR1 P36897 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1208893 0.92 PTPN5 (0.54) PTPN5NOD1TNFMEN1KMT2A
SCHEMBL1207384 0.91 PTPN5 (0.51) PTPN5NOD1TNFMEN1KMT2A
SCHEMBL1208981 0.91 PTPN5 (0.51) PTPN5NOD1TNFMEN1KMT2A
SCHEMBL1210023 0.91 PTPN5 (0.53) PTPN5NOD1TNFMEN1KMT2A
SCHEMBL1209368 0.91 NOD1 (0.50) PTPN5NOD1TNFMEN1KMT2A
SCHEMBL1210279 0.90 NOD1 (0.49) PTPN5NOD1TNFMEN1KMT2A
SCHEMBL1209087 0.90 NOD1 (0.49) PTPN5NOD1TNFMEN1KMT2A
SCHEMBL1210389 0.90 PTPN5 (0.53) PTPN5NOD1TNFMEN1KMT2A
SCHEMBL1209434 0.89 NOD1 (0.49) PTPN5NOD1TNFMEN1KMT2A
SCHEMBL1209899 0.89 NOD1 (0.51) PTPN5NOD1TNFMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed
EP-2051974-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2009-04-29 EP disclosed
WO-2008020045-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES BAX, BCL2, BAD PTPN5 1174/4885NOD1 2383/4885TNF 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.